Zepp Health (ZEPP) Cash & Equivalents (2016 - 2026)

Zepp Health (ZEPP) has reported Cash & Equivalents for 11 consecutive years, with $52.4 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 68558954.81% year-over-year to $52.4 billion; the TTM figure through Mar 2026 stood at $52.4 billion (up 68558954.81% YoY), while the FY2025 annual figure was $57046.0 billion, up 62640315.51% from the prior year.
• Cash & Equivalents came in at $52.4 billion for Q1 2026 at Zepp Health, down from $57046.0 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $131809.1 billion in Q4 2023, with the low at $76429.0 in Q1 2025.
• Average Cash & Equivalents over 5 years is $11168.1 billion, with a median of $61.7 billion recorded in 2025.
• Across the five-year window, Cash & Equivalents surged 105731351.96% in 2023 and tumbled 100.0% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $124.7 million in 2022, then jumped by 105731351.96% to $131809.1 billion in 2023, then sank by 100.0% to $91.1 million in 2024, then jumped by 62640315.51% to $57046.0 billion in 2025, then tumbled by 99.91% to $52.4 billion in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $52.4 billion, $57046.0 billion, and $61.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.